Cipla
Company Details
Linkedin ID:
cipla
Website:
Employees number:
49,702
Number of followers:
1,999,660
NAICS:
3254
Industry Type:
Homepage:
cipla.com
IP Addresses:
0
Company ID:
CIP_8144792
Scan Status:
In-progress
Cipla Company CyberSecurity Posture
cipla.com
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.
Cipla A.I CyberSecurity Scoring
Cipla Risk Score (AI oriented)Between 750 and 799
Cipla
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
Cipla Global Score (TPRM)XXXX
Cipla
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
Cipla Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
Cipla Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for Cipla
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Cipla in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Cipla in 2025.
Incident Types Cipla vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Cipla in 2025.
Incident History — Cipla (X = Date, Y = Severity)
Cipla cyber incidents detection timeline including parent company and subsidiaries
Cipla Company Subsidiaries
Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.
Loading...
Cipla Similar Companies
Sandoz
Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health c
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working t
At Lonza, we enable A Healthier World by supporting our healthcare customers on the path to commercialization. Our community of 16,000 talented employees work across a global network of more than 30 sites to deliver for our customers across the pharma, biotech and nutrition markets. By combining t
PT Kalbe Farma, Tbk
Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching t
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out mor
Merck Group
This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trad
MENARINI Group
The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic
We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing t
Servier
Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its
.png)
Cipla CyberSecurity News
July 25, 2025 07:00 AM
Cipla gains after Q1 PAT rises 10% YoY to Rs 1,298 crore
Cipla rallied 3.59% to Rs 1540.70 after the company reported 10.18% increase in consolidated net profit to Rs 1297.62 crore on a 3.93% rise...
April 17, 2025 07:00 AM
Infosys to acquire Australian cybersecurity services provider - The Missing Link
Infosys announced a definitive agreement to acquire The Missing Link, an award winning Australian cybersecurity services specialist firm.
April 09, 2025 07:00 AM
Indian pharma stocks tumble as Trump signals tariffs on drug imports
India Business News: Indian pharmaceutical stocks experienced a downturn following Donald Trump's renewed threat to impose tariffs on...
April 02, 2025 07:00 AM
Domestic pharma sector on edge as US tariffs loom
India Business News: Indian pharma companies brace for potential US tariffs that could raise drug prices, disrupt supply chains,...
December 11, 2024 08:00 AM
Cipla Reportedly Hacked by Akira Ransomware Group, 70GB of Sensitive Data Allegedly Stolen
Cipla, one of India's leading pharmaceutical companies, has reportedly been targeted by the Akira ransomware group in a cyberattack that allegedly resulted in...
December 09, 2024 08:00 AM
Cipla Allegedly Hacked, Akira Ransomware Claims 70GB Data Stolen
Cipla, the Indian pharmaceutical giant, has reportedly fallen victim to a cyberattack orchestrated by the Akira ransomware group.
May 13, 2024 12:18 AM
Startup Uncovered Chinese Hackers' Plot To Target Indian Cyberspace
Cyfirma, a Singapore-based cyber-security research firm, recently confirmed that hacking groups working closely with the Chinese government were planning a...
September 21, 2023 07:00 AM
Cipla's US subsidiary InvaGen gets 5 inspectional observations from USFDA
Cipla announced that the United States Food and Drug Administration (USFDA) had conducted an inspection at its wholly-owned subsidiary, InvaGen Pharmaceuticals.
February 23, 2023 06:03 PM
Samina Hamied
A third-generation heir to Cipla and a fitness enthusiast, Samina Hamied is a marathon runner both in the business world and on the track.
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
Cipla CyberSecurity History Information
Official Website of Cipla
The official website of Cipla is http://www.cipla.com.
Cipla’s AI-Generated Cybersecurity Score
According to Rankiteo, Cipla’s AI-generated cybersecurity score is 787, reflecting their Fair security posture.
How many security badges does Cipla’ have ?
According to Rankiteo, Cipla currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Cipla have SOC 2 Type 1 certification ?
According to Rankiteo, Cipla is not certified under SOC 2 Type 1.
Does Cipla have SOC 2 Type 2 certification ?
According to Rankiteo, Cipla does not hold a SOC 2 Type 2 certification.
Does Cipla comply with GDPR ?
According to Rankiteo, Cipla is not listed as GDPR compliant.
Does Cipla have PCI DSS certification ?
According to Rankiteo, Cipla does not currently maintain PCI DSS compliance.
Does Cipla comply with HIPAA ?
According to Rankiteo, Cipla is not compliant with HIPAA regulations.
Does Cipla have ISO 27001 certification ?
According to Rankiteo,Cipla is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Cipla
Cipla operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Cipla
Cipla employs approximately 49,702 people worldwide.
Subsidiaries Owned by Cipla
Cipla presently has no subsidiaries across any sectors.
Cipla’s LinkedIn Followers
Cipla’s official LinkedIn profile has approximately 1,999,660 followers.
NAICS Classification of Cipla
Cipla is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Cipla’s Presence on Crunchbase
No, Cipla does not have a profile on Crunchbase.
Cipla’s Presence on LinkedIn
Yes, Cipla maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/cipla.
Cybersecurity Incidents Involving Cipla
As of November 27, 2025, Rankiteo reports that Cipla has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Cipla has an estimated 5,260 peer or competitor companies worldwide.
Cipla CyberSecurity History Information
How many cyber incidents has Cipla faced ?
Total Incidents: According to Rankiteo, Cipla has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Cipla ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
Angular is a development platform for building mobile and desktop web applications using TypeScript/JavaScript and other languages. Prior to versions 19.2.16, 20.3.14, and 21.0.1, there is a XSRF token leakage via protocol-relative URLs in angular HTTP clients. The vulnerability is a Credential Leak by App Logic that leads to the unauthorized disclosure of the Cross-Site Request Forgery (XSRF) token to an attacker-controlled domain. Angular's HttpClient has a built-in XSRF protection mechanism that works by checking if a request URL starts with a protocol (http:// or https://) to determine if it is cross-origin. If the URL starts with protocol-relative URL (//), it is incorrectly treated as a same-origin request, and the XSRF token is automatically added to the X-XSRF-TOKEN header. This issue has been patched in versions 19.2.16, 20.3.14, and 21.0.1. A workaround for this issue involves avoiding using protocol-relative URLs (URLs starting with //) in HttpClient requests. All backend communication URLs should be hardcoded as relative paths (starting with a single /) or fully qualified, trusted absolute URLs.
Risk Information
cvss4
Base: 7.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
- https://github.com/angular/angular/commit/0276479e7d0e280e0f8d26fa567d3b7aa97a516f
- https://github.com/angular/angular/commit/05fe6686a97fa0bcd3cf157805b3612033f975bc
- https://github.com/angular/angular/commit/3240d856d942727372a705252f7c8c115394a41e
- https://github.com/angular/angular/releases/tag/19.2.16
- https://github.com/angular/angular/releases/tag/20.3.14
- https://github.com/angular/angular/releases/tag/21.0.1
- https://github.com/angular/angular/security/advisories/GHSA-58c5-g7wp-6w37
Description
Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Uncontrolled Recursion vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft deep ASN.1 structures that trigger unbounded recursive parsing. This leads to a Denial-of-Service (DoS) via stack exhaustion when parsing untrusted DER inputs. This issue has been patched in version 1.3.2.
Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Integer Overflow vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft ASN.1 structures containing OIDs with oversized arcs. These arcs may be decoded as smaller, trusted OIDs due to 32-bit bitwise truncation, enabling the bypass of downstream OID-based security decisions. This issue has been patched in version 1.3.2.
Risk Information
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. Prior to versions 7.0.13 and 8.0.2, working with large buffers in Lua scripts can lead to a stack overflow. Users of Lua rules and output scripts may be affected when working with large buffers. This includes a rule passing a large buffer to a Lua script. This issue has been patched in versions 7.0.13 and 8.0.2. A workaround for this issue involves disabling Lua rules and output scripts, or making sure limits, such as stream.depth.reassembly and HTTP response body limits (response-body-limit), are set to less than half the stack size.
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description
Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. In versions from 8.0.0 to before 8.0.2, a NULL dereference can occur when the entropy keyword is used in conjunction with base64_data. This issue has been patched in version 8.0.2. A workaround involves disabling rules that use entropy in conjunction with base64_data.
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=cipla' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
